Related Experiment Video

Updated: Jul 29, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Molecular targeting of gene therapy and radiotherapy

R R Weichselbaum1, D W Kufe, S J Advani

  • 1Department of Radiation and Cellular Oncology, The Pritzker School of Medicine, The University of Chicago, Illinois 60637, USA. rrw@rover.bsd.uchicago.edu

Acta Oncologica (Stockholm, Sweden)
|January 5, 2002
PubMed

Insights

This study explores combining gene therapy with radiotherapy to improve cancer treatment. Radiation-inducible gene therapy and engineered herpes simplex virus (HSV-1) show potential for enhanced antitumor efficacy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biotechnology

Background:

  • Gene therapy's potential is hindered by poor tumor specificity and transgene efficacy.
  • Radiotherapy is a cornerstone of cancer treatment but can affect healthy tissues.

Purpose of the Study:

  • To investigate novel gene therapy strategies combined with radiotherapy for enhanced cancer treatment.
  • To address limitations in current gene therapy delivery and efficacy.

Main Methods:

  • Developed radiation-inducible gene therapy using Egr-1 promoter elements to drive TNFalpha expression in tumors.
  • Engineered herpes simplex virus (HSV-1) to be selectively induced by ionizing radiation for tumor proliferation.

Main Results:

  • Radiation-inducible gene therapy allows targeted transgene expression (TNFalpha) within the tumor microenvironment.
  • Genetically modified HSV-1 demonstrates radiation-induced proliferation specifically within tumor volumes.

Conclusions:

  • Combining radiotherapy with radiation-inducible gene therapy or engineered HSV-1 offers a promising approach to improve treatment efficacy.
  • These synergistic strategies enhance both gene therapy delivery and radiotherapy's antitumor effects.

More Related Videos

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes08:32

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...